In This Section

Program

Please note that this meeting will take place as an in-person event in Philadelphia and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

*-Short talk from proffered abstract

[R] – Remote Presentation

TUESDAY, JANUARY 13

WEDNESDAY, JANUARY 14

THURSDAY, JANUARY 15

Tuesday, January 13

Welcome and Keynote Lectures 

4-6 p.m.

Session Chair: Kimberly Stegmaier, Dana-Farber Cancer Institute, Boston, Massachusetts

  • 4:15 p.m. | Olivier Delattre, Institute Curie, Paris, France
  • 5 p.m. | Arul Chinnaiyan, University of Michigan, Ann Arbor, Michigan

Break

5:45-6 p.m.

Plenary Session 1: Fusion oncogenes—Discovery to treatment

6-7 p.m.

  • 6 p.m. | Cristina Antonescu, Memorial Sloan Kettering Cancer Center, New York, New York
  • 6:30 p.m. | Sandy Simon, The Rockefeller University, New York, New York

Opening Reception and Poster Session A 

7-9 a.m.

Wednesday, January 14

Plenary Session 2: Genetics, cellular origins, and model systems

8-10 a.m.

  • 8 a.m. | Jim Amatruda, Children’s Hospital of Los Angeles, Los Angeles, California
  • 8:30 a.m. | Jeffrey MaGee, Washington University School of Medicine, St. Louis, Missouri
  • 9 a.m. | Mark Hatley, St. Jude Children’s Research Hospital, Memphis, Tennessee

Short talks selected from proffered abstracts

Break

10-10:30 a.m.

Plenary Session 3: Mechanism Based Therapeutics

10:30 a.m.-12:30 p.m.

Session Chair: Ross A. Okimoto, University of California San Francisco, San Francisco, California

  • 10:30 a.m. | Scott Armstrong, Dana-Farber Cancer Institute, Boston, Massachusetts
  • 11:15 a.m. | Hua Yu, City of Hope National Medical Center, Duarte, California
  • 11:45 a.m. | Ross A. Okimoto, University of California San Francisco, San Francisco, California

Short talk selected from proffered abstracts

Lunch on own

12:30-2:30 p.m.

Plenary Session 4: Condensates: Fact or Fusion?

2:30-4:15 p.m.

Session Chair: Natasha Caplen, National Cancer Institute, Bethesda, Maryland

  • 2 p.m. | Danfeng Cai, Johns Hopkins University, Baltimore, Maryland
  • 2:30 p.m. | Lukasz Bugaj, University of Pennsylvania, Philadelphia, Pennsylvania
  • 3 p.m. | Natasha Caplen, National Cancer Institute, Bethesda, Maryland
  • 3:30 p.m. | Miguel Rivera, Massachusetts General Hospital, Boston, Massachusetts

Short talk selected from proffered abstracts

Break

4:15-4:30 p.m.

Plenary Session 5: Translating Discoveries toward New therapies

4:30-6:30 p.m.

  • 4:30 p.m. | Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, New York
  • 5 p.m. | Jolanta Grembecka, University of Michigan, Ann Arbor, Michigan
  • 5:30 p.m. | Jessica Jiyeong Lin, Massachusetts General Hospital, Boston, Massachusetts
  • 6 p.m. | Jia Luo, Dana-Farber Cancer Institute, Boston, Massachusetts

Lightning Talks

6:30-7 p.m.

Reception and Posters B

7-9 p.m.

Thursday, January 15

Plenary Session 6: Gene Regulatory Mechanisms of Oncoproteins

8-10 a.m.

  • 8 a.m. | Stephen Mack, St. Jude Children’s Research Hospital, Memphis, Tennessee
  • 8:30 a.m. | Genevieve Kendall, Nationwide Children’s Hospital, Columbus, Ohio
  • 9 a.m. | Eleni Tomazou, St. Anna children’s Cancer Research Institute, Vienna, Austria
  • 9:30 a.m. | Brian Rubin, Cleveland Clinic, Cleveland, Ohio

Break

10-10:30 a.m.

Plenary Session 7: Discovery of new targets with Functional and Chemical Genomics

10:30 a.m.-12:45 p.m.

  • 10: 30-11:00 a.m. | Daniel Nomura, University of California Berkeley, Berkeley, California
  • 11 a.m. | David McFadden, University of Texas Southwestern Medical Center, Dallas, Texas
  • 11:30 a.m. | Kimberly Stegmaier, Dana-Farber Cancer Institute, Boston, Massachusetts
  • 12 p.m. | Pratiti (Mimi) Bandopadhayay, Dana-Farber Cancer Institute, Boston, Massachusetts

Closing Remarks

12:30 p.m.